S124: ADVERSE EVENTS FOLLOWING COVID-19 VACCINATION IN TRANSFUSION-DEPENDENT -THALASSEMIA PATIENTS

por Delaporta, P, Kyriakopoulou, D, Ioakeimidou, N, Solomou, E, Binenbaum, I, Toutoudaki, K, Chatzielefteriou, M, Papassotiriou, I, Kattamis, A
Publicado 2022

P1506: REAL-WORLD DATA ON THE USE OF LUSPATERCEPT IN GREEK PATIENTS WITH TRANSFUSION DEPENDENT THALASSEMIA

por Delaporta, P., Delicou, S., Kouraklis-Symeonidis, A., Diamantidis, M., Vlachaki, E., Xydaki, A., Labropoulou, V., Lazaris, V., Michalitsis, M., Klonizakis, P., Toutoudaki, K., Chatzieleftheriou, M.-I., Kyriakopoulou, D., Kattamis, A.
Publicado 2022

P1507: CLINICAL PROFILE OF COVID-19 INFECTION AND IMMUNE RESPONSE AFTER 3AND6 MONTH VACCINATION AGAINST SARS-COV-2 IN ADULT PATIENTS WITH TRANSFUSION-DEPENDENT THALASSAEMIA-THE EXP...

por Delaporta, P., Terpos, E., Solomou, E. E., Gumeni, S., Chatzielefteriou, M.-I., Toutoudaki, K., Kyriakopoulou, D., Ioakeimidou, N., Ntanasis-Stathopoulos, I., Papassotiriou, I., Trougakos, I. P., Dimopoulos, M. A., Kattamis, A.
Publicado 2022